LLY
Eli Lilly and Company
$1,223.00
▲ +1.23%
+$14.88
NYSE · Healthcare · Drug Manufacturers - General
Eli Lilly and Company
LLY · NYSE · Healthcare · Drug Manufacturers - General
$1,223.00
▲ +1.23% · +$14.88 today
fundamentals82.5 /100 vs peers
strong
Revenue growth (TTM)47.4
strong pace
EPS growth (TTM)130.0
strong pace
EPS forecast (5Y)28.5
strong pace
EPS next year21.8
strong pace
EPS growth (Q/Q)169.4
strong pace
Compared against sector peers where available.
vs sector peers
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| LLYEli Lilly and Company | $1.09T | 43.4 | +47.4% | 83 |
| INDVIndivior | $4.59B | 19.1 | -0.3% | 84 |
| DXCMDexcom | $28.11B | 31.2 | +16.1% | 76 |
| GMEDGlobus Medical | $10.85B | 18.6 | +23.5% | 76 |
| GILDGilead Sciences Inc. | $160.36B | 17.6 | +3.5% | 74 |
